Verizon insider Kyle Malady sells 1,100 shares at $43, showing confidence in the company’s long‑term 5G growth while balancing liquidity—insight for investors.
Verizon insider Kyle Malady sold 1,100 shares at $42.93, a routine liquidity move amid growing AI, drone, and fiber strategy; phantom‑stock buys signal confidence in long‑term growth.
Verizon insider Kyle Malady sells 1,100 shares under a 10b5‑1 plan, revealing routine trading habits, regulatory compliance, and confidence in the company’s 5G‑fiber growth prospects.